151 related articles for article (PubMed ID: 35060925)
1. Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers.
White G; Velusamy A; Anandappa S; Masucci M; Breen LA; Joshi M; McGowan B; Hubbard JGH; Obholzer R; Christodoulou D; Jacques A; Touska P; Hassan FU; Izatt L; Carroll PV
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35060925
[TBL] [Abstract][Full Text] [Related]
2. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
[TBL] [Abstract][Full Text] [Related]
3. First-positive surveillance screening in an asymptomatic SDHA germline mutation carrier.
White G; Tufton N; Akker SA
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019(1):. PubMed ID: 31368675
[TBL] [Abstract][Full Text] [Related]
4. Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
Barbolosi D; Crona J; Serre R; Pacak K; Taieb D
PLoS One; 2018; 13(8):e0201303. PubMed ID: 30106970
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma.
Muth A; Crona J; Gimm O; Elmgren A; Filipsson K; Stenmark Askmalm M; Sandstedt J; Tengvar M; Tham E
J Intern Med; 2019 Feb; 285(2):187-204. PubMed ID: 30536464
[TBL] [Abstract][Full Text] [Related]
6. Risk of metastatic pheochromocytoma and paraganglioma in
Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma.
Thompson MJ; Parameswaran V; Burgess JR
Ann Clin Biochem; 2019 Jan; 56(1):163-169. PubMed ID: 30373390
[TBL] [Abstract][Full Text] [Related]
8. Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.
Daniel E; Jones R; Bull M; Newell-Price J
Eur J Endocrinol; 2016 Dec; 175(6):561-570. PubMed ID: 27634942
[TBL] [Abstract][Full Text] [Related]
9. Increased Mortality in
Rijken JA; van Hulsteijn LT; Dekkers OM; Niemeijer ND; Leemans CR; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Dreijerink KMA; van Dooren MF; Hes FJ; Jansen JC; Corssmit EPM; Hensen EF
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30658386
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers.
Tufton N; Shapiro L; Srirangalingam U; Richards P; Sahdev A; Kumar AV; McAndrew L; Martin L; Berney D; Monson J; Chew SL; Waterhouse M; Druce M; Korbonits M; Metcalfe K; Drake WM; Storr HL; Akker SA
Clin Endocrinol (Oxf); 2017 Feb; 86(2):286-296. PubMed ID: 27678251
[TBL] [Abstract][Full Text] [Related]
12. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype associations in PPGLs in 59 patients with variants in SDHX genes.
Main AM; Rossing M; Borgwardt L; Grønkær Toft B; Rasmussen ÅK; Feldt-Rasmussen U
Endocr Connect; 2020 Aug; 9(8):793-803. PubMed ID: 32688340
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
[TBL] [Abstract][Full Text] [Related]
15. Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?
Tufton N; Sahdev A; Drake WM; Akker SA
Clin Endocrinol (Oxf); 2019 Jan; 90(1):31-46. PubMed ID: 30303539
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma.
Yonamine M; Wasano K; Aita Y; Sugasawa T; Takahashi K; Kawakami Y; Shimano H; Nishiyama H; Hara H; Naruse M; Okamoto T; Matsuda T; Kosugi S; Horiguchi K; Tanabe A; Watanabe A; Kimura N; Nakamura E; Sakurai A; Shiga K; Takekoshi K
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439168
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
19. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
